Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

The availability of a reproducible and clinically relevant scale for grading angiographic outcomes following acute stroke intervention would facilitate both research endeavors and clinical practice. For several decades, interventional cardiologists have used the Thrombolysis in Myocardial Infarction (TIMI) scale to describe angiographic findings following coronary revascularization procedures.1 In 2003, the Technology Assessment Committees of the American Society of Interventional and Therapeutic Neuroradiology and the Society of Interventional Radiology proposed a seemingly simple and direct modification of the TIMI scale to describe angiographic findings following acute stroke intervention, termed the Thrombolysis in Cerebral Infarction (TICI) scale.2 This scale and its many derivatives are widely referenced in the literature. Unfortunately, the TICI scale contains internal inconsistencies that render it and its derivatives impossible to apply in practice.

The TIMI scale assesses a single characteristic of angiographic outcomes, namely, rapidity of antegrade flow. Progressing from TIMI 0, with no antegrade flow, to TIMI 3, with a normal rate of antegrade flow, the TIMI scale simply assesses how fast contrast reaches the distal vasculature. Because stroke intervention frequently results in reopening of some but not all branches in a specific territory, the TICI authors added an apparently benign subcategorization in 1 of the 4 TIMI grades. Specifically, TIMI 2, in which contrast opacifies the capillary bed but in a delayed fashion, was subcategorized into TICI grades 2a and 2b. For these subcategories, predicated on delayed antegrade flow and thus inhabiting grade 2, TICI 2a applied to cases in which less than two-thirds of the vascular bed was revascularized, whereas TICI 2b applied when “Complete filling of all of the expected vascular territory is visualized….”2

Careful reading of the TICI definition begs the question, “How does one grade cases in which greater than two-thirds but less than ‘complete' filling of the territory is noted?” For example, a patient in whom 80% of the MCA territory is opened is not defined in the TICI scale because this is “better” than 2a but “worse” than 2b— that is, impossible to assign any TICI grade (Fig 1). This shortcoming alone renders the original TICI scale cumbersome, at best, to apply in either clinical or research settings.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

A, Lateral DSA following acute stroke intervention shows delay in flow in the posterior division of the MCA (arrows) compared with the anterior cerebral artery branches. B, Late arterial phase shows opacification of nearly all of the MCA. Because this represents more than two-thirds of the MCA (and thus not TICI 2a) but not “complete filling” (and thus not TICI 2b), it cannot be categorized by using the original TICI classifications.

But, things get worse. On the basis of the original TICI definition, in category 2, either antegrade flow into or rate of clearance from the distal territory must be delayed. How, then, does one classify a case in which a portion of the MCA is opened and in which this revascularized bed demonstrates a normal rate of antegrade flow (Fig 2)? In TIMI, only grade 3 applies to normal rates of antegrade flow. In TICI, does a partially revascularized MCA territory with normal rate of distal opacification indicate grade 2, grade 3, or neither? As above, this (common) angiographic outcome, with partial revascularization demonstrating excellent antegrade flow, cannot be graded by using the original TICI definition.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Lateral DSA following acute stroke intervention shows a normal rate of antegrade flow in most of the MCA territory, with only a small amount of nonperfused parenchyma (arrows). The branches with normal antegrade flow would go into the TICI 3 category, while those with absent antegrade flow would go in the TICI 0 category, but there is no single TICI category for this angiogram. Some reviewers might want to put it into TICI 2, but it would not fit for 2 reasons: First, there is no portion of the territory with slow perfusion; second, the perfused area is greater than two-thirds of the MCA territory (making it incompatible with TICI 2a) but less than 100% of the MCA territory (making it incompatible with TICI 2b).

And, that is not all. Leptomeningeal collateral flow may have a profound impact on outcome, yet it remains unclear how the TICI scale accounts for such flow. Is a case with a persistent M1 occlusion but robust anterior cerebral artery to MCA leptomeningeal collateral flow with full (but retrograde) MCA opacification graded as TICI 0 or is it a TICI 3 (Fig 3)?

Fig 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 3.

A, Anteroposterior DSA following acute stroke intervention shows persistent occlusion of the MCA. B, Late arterial phase DSA in the same patient as in A shows robust, retrograde, anterior cerebral artery−MCA leptomeningeal flow with opacification of most of the MCA territory.

Tomsick, in 2007,3 confessed confusion about the revascularization scales. He was not completely confused, though, and correctly pointed out that both opening of the occlusion as well as distal perfusion are relevant clinically but that available scales usually failed to capture both of these characteristics. However, he did not, at that time, point out the internal inconsistencies of TICI and has himself applied a modified TICI scale in previous and ongoing clinical trials.4

Does this even matter? Yes. As industry develops new and better devices for us, approval agencies likely will require objective, clinically relevant, and usable scales to assess device efficacy. Furthermore, communication among the research community and among clinicians is possible only if each party is speaking the same language.

Can TICI be fixed? Possibly, but fixing TICI is not a trivial endeavor. First, it might need to be reconfigured to apply to all of the potential combinations of absent/slow/normal antegrade flow was well as fractions of the distal territory perfused. Second, interobserver variability would need to be assessed. Third, correlation with clinical outcome would be needed. Finally, accounting for collateral flow would be ideal.

As noted above, other scales in addition to TICI have been proposed for grading angiographic outcomes following stroke intervention. Some have added a “2c” subcategory,5 some use 50% rather than two-thirds as the cutoff between 2a and 2b,6 and some have inclusion of collateral flow in the outcomes.7 I remain agnostic as to what scale is ultimately applied, as long as such a scale is sensible, easily implemented, reproducible, and clinically relevant. Hopefully those researchers planning to use the TICI scale or its derivatives will recognize its inherent inconsistencies and either fix them or move on.

References

  1. 1.
    The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings—TIMI Study Group. N Engl J Med 1985 312 932–36
  2. 2.
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H,
    4. et al
    . Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37
  3. 3.
    1. Tomsick T
    . TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol 2007;28:382–84
  4. 4.
    1. Tomsick T,
    2. Broderick J,
    3. Carrozella J,
    4. et al
    . Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582–87
  5. 5.
    1. Noser EA,
    2. Shaltoni HM,
    3. Hall CE,
    4. et al
    . Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292–96
  6. 6.
    IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127–35. Epub 2007 May 24
  7. 7.
    1. Qureshi AI
    . New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50:1405–14, discussion 14–15
  • © 2012 by American Journal of Neuroradiology
Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire